 Featured News June 16, 2008
Med BioGene Expands Lymphoma Collaboration; Becomes Founding Corporate Collaborator of Translational Working Group in Hematologic Malignancies
May 29, 2008
Med BioGene Appoints Diagnostics Industry Veteran Dr. Heiner Dreismann to Board of Directors
April 23, 2008
Med BioGene and University Health Network Collaborate to Commercialize Critical Lung Cancer Prognostic Test
|
News Archives 2006 May 05, 2006
Med BioGene Inc. Completes Acquisition of Dragon-Tex (Group) Limited and Dragon-Tex (Group) Limited and $2 Million Financing
May 19, 2006
Med BioGene Inc. Appoints Erinn B. Broshko as its New Chief Executive Officer and a Director
June 23, 2006
Med BioGene Inc. Signs Letter of Intent with the Ontario Institute for Cancer Research
June 30, 2006
Med BioGene Inc. Receives Ethics Board Approval from the Ontario Cancer Research Ethics Board; Signs Material Transfer Agreement with the Ontario Institute for Cancer Research
July 11, 2006
Med BioGene Inc.’s Chief Scientific Officer to Present at Prestigious P.O.E.T.I.C. Conference to be held July 19-21 in Banff, Alberta
August 01, 2006
Med BioGene Inc. Receives Renewed Ethics Board Approval from Vancouver Coastal Health Authority; Expects to Release Pre-Clinical Results of Diagnostic Lymphoma Bioarray Shortly
August 03, 2006
Med BioGene Reports Promising Pre-Clinical Results of its Diagnostic Lymphoma DNA Bioarray; Biomarkers Effective in Diagnosing Major Lymphoma Subtypes
September 25, 2006
Med BioGene Enters Development and Validation Phase for its Cardiovascular Disease Profiling System™; Begins Joint Pilot Project with Ottawa Heart Institute Research Corporation
November 29, 2006
Med BioGene Appoints John H. Rayson, M.D. as Chairman of the Board; Reports Financial Results for Third Quarter 2006
|
E-MAIL ALERTS
Subscribe to our e-mail news alerts
Quick Facts
Download our facts sheet
|
Home 
© Copyright 2006 - Med BioGene Inc. - Legal Disclaimer